vimarsana.com
Home
Live Updates
Key Trials at ASCO 2023 Highlight Role of Perioperative Treatment Approaches in NSCLC : vimarsana.com
Key Trials at ASCO 2023 Highlight Role of Perioperative Treatment Approaches in NSCLC
Jarushka Naidoo, MBBCh, discussed the clinical significance of datasets from several phase 3 trials presented at the 2023 ASCO Annual Meeting, including ADAURA, KEYNOTE-617, CheckMate 816, and CheckMate 9LA trials.
Related Keywords
Ireland ,
Dublin ,
Jarushka Naidoo ,
Heather Wakelee ,
Stanford Health ,
European Medicines Agency ,
Royal College Of Surgeons Ireland Cancer Centre ,
News Network ,
Royal College ,
Surgeons Ireland Cancer Centre ,
Beaumont Hospital ,
Treating Field ,
Amivantamab Plus Lazertinib ,
Patients With Egfr Mutated Non Small Cell Lung Cancer ,
Nct04077463 ,
Pasco ,
Nsclc ,
Mbbch ,
Checkmate 816 ,
Keynote 617 ,
Daura ,
Checkmate 9la ,
Lunar ,
Artemide 01 ,
Keynote 789 ,
vimarsana.com © 2020. All Rights Reserved.